Merck today announced that Rock 'n Roll Hall of Famer Gregg Allman will work together with the company and the American Liver Foundation on Tune In to Hep C, a public health campaign to help raise awareness of chronic hepatitis C virus infection. To help turn up the volume around hepatitis C a benefit concert featuring. The Allman Brothers Band will be held at the Beacon Theatre in New York on July 27, the eve of World Hepatitis Day.
This week marks the one-year anniversary of Allman's liver transplant, which he received after his liver had become damaged from chronic hepatitis C infection. Allman has returned to performing and recording music, and now wants to help raise awareness of hepatitis C.
I'm excited to be working with Merck and the American Liver Foundation because there are many people who have been diagnosed with chronic hepatitis C, but aren't taking action. I want to tell them, don't wait. Doing nothing is not an option; they need to talk with their doctor," said Allman, a founding member of The Allman Brothers Band. I made the decision to take action and talk to my doctor, so that I could get back to making the music I love. I want others to take that action too, and if I can help make that happen, I've done my job."
Nearly 3.2 million Americans have chronic hepatitis C virus infection, a potentially serious disease that can damage the liver over time and lead to cirrhosis, end-stage liver disease and liver cancer. Many people infected with chronic hepatitis C do not know that they have the virusapproximately 60 to 80 percent of people infected with chronic hepatitis C virus do not have symptoms.
The American Liver Foundation (ALF) joined the Tune In to Hep C campaign to help elevate awareness of this important public health issue. ALF is a national organization advocating for those living with liver disease and their families, and provides education, support and research for the prevention, treatment and cure of liver disease.